Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 121.82M P/E - EPS this Y 11.10% Ern Qtrly Grth -
Income -22.08M Forward P/E -8.39 EPS next Y 25.00% 50D Avg Chg -14.00%
Sales 23.75M PEG - EPS past 5Y - 200D Avg Chg -23.00%
Dividend N/A Price/Book 4.78 EPS next 5Y - 52W High Chg -45.00%
Recommedations 2.20 Quick Ratio 1.43 Shares Outstanding 84.66M 52W Low Chg 6.00%
Insider Own 15.65% ROA -32.18% Shares Float 58.41M Beta 1.56
Inst Own 48.27% ROE -94.89% Shares Shorted/Prior 3.27M/3.23M Price 1.51
Gross Margin 59.28% Profit Margin -87.38% Avg. Volume 325,970 Target Price 4.50
Oper. Margin -133.74% Earnings Date Nov 7 Volume 154,700 Change 1.34%
About Stereotaxis, Inc.

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Stereotaxis, Inc. News
12/16/24 STXS Stock Up Post NMPA Nod for Cardiovascular Care With Magbot
12/10/24 NMPA approves Stereotaxis and MicroPort’s ablation catheter
12/09/24 Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China’s NMPA
12/02/24 Stereotaxis’ GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems
11/26/24 STXS Stock Up Following the NMPA Clearance of Its Genesis RMN System
11/26/24 Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference
11/25/24 Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China
11/20/24 Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System
11/12/24 Stereotaxis Reports Strong Q3 Growth in Robotics
11/12/24 Q3 2024 Stereotaxis Inc Earnings Call
11/11/24 Stereotaxis Inc. (STXS) Reports Q3 Loss, Tops Revenue Estimates
11/11/24 Stereotaxis Reports 2024 Third Quarter Financial Results
11/08/24 Delcath Systems, Inc. (DCTH) Reports Q3 Loss
11/07/24 Avinger (AVGR) Reports Q3 Loss, Tops Revenue Estimates
11/07/24 Kansas health centre adopts Stereotaxis’ endovascular robot
11/06/24 University of Kansas Medical Center Enhances Robotic Heart Care Program with Genesis Robotic Technology
10/23/24 Stereotaxis to Report Third Quarter 2024 Financial Results on November 11, 2024
10/21/24 Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation
09/09/24 Stereotaxis to Present at Upcoming Investor Conferences
09/03/24 Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society’s HRX Congress
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Isaac Paul J Director Director Dec 15 Buy 1.72 11,060 19,023 2,739,693 12/18/23
Isaac Paul J Director Director Nov 21 Buy 1.52 6,018 9,147 2,725,825 11/24/23
Isaac Paul J Director Director Nov 17 Buy 1.55 12,000 18,600 2,719,807 11/21/23
Isaac Paul J Director Director Nov 15 Buy 1.48 35,000 51,800 2,707,807 11/17/23
Isaac Paul J Director Director Nov 13 Buy 1.45 20,000 29,000 2,672,807 11/15/23
Isaac Paul J Director Director Sep 14 Buy 1.64 23,168 37,996 2,652,807 09/18/23
Isaac Paul J Director Director Sep 12 Buy 1.68 7,505 12,608 2,629,639 09/14/23
Isaac Paul J Director Director Aug 30 Buy 1.71 10,000 17,100 2,622,134 09/01/23
Isaac Paul J Director Director Aug 28 Buy 1.71 16,050 27,446 2,612,134 08/30/23
Isaac Paul J Director Director Aug 24 Buy 1.75 9,000 15,750 2,596,084 08/28/23
Isaac Paul J Director Director May 25 Buy 1.83 14,300 26,169 2,528,583 06/01/22
Isaac Paul J Director Director May 23 Buy 1.83 14,292 26,154 2,514,283 05/25/22
Isaac Paul J Director Director May 16 Buy 1.82 55,025 100,146 2,456,728 05/19/22
Isaac Paul J Director Director May 12 Buy 1.83 156,751 286,854 2,401,703 05/16/22